12 months Roche PH launches immunotherapy for previously treated non-small cell lung cancer MB |LS
As Global Lung Cancer Awareness Month was marked last November, Filipinos need to be more aware of lung cancer, how it is diagnosed, and the latest treatment options available for patients. Dr. James Ho explains the cancer-immunity cycle and benefits of Atezolizumab for patients with locally-advanced or metastatic non-small cell lung cancer According to the latest 2018 statistics, lung cancer remains to be the most common cause of cancer-related deaths in the Philippines. Most cases of lung cancer present at an advanced stage of disease, when it is already metastatic and surgery is not an option anymore. Lung cancer can ... more